•  
  •  
  •  
  •  

2026-05-30 18:57:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • XTGlobal Infotech Limited Delivers Stellar Performance with ~39% Jump in PAT YoY
  • Mini Diamonds India Ltd announces Launch of Fancy Coloured LabGrown Diamond Jewellery Line through Namra Jewels Pvt Ltd
  • Gaudium IVF Delivers Record Q4FY26: Revenue, EBITDA and PAT
  • Unimech Aerospace and Manufacturing Ltd delivers strong Q4 FY26 Performance
  • EFC India Ltd reports strong results powering next phase of growth

Keywords Selected:  Pharma

Research

  • Anand Rathi Report: India Pharma - Healthy growth in Dec'22; volumes slow down
  • Quant Thematic - Three factor model for stocks filtration
  • Aurobindo Pharma - Entry into India - a little too late?
  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Stock Report

  • Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT
  • Classification of Unit-I of Eugia Pharma Specialities Ltd, Shameerpet as OAI
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport
  • OneSource Specialty Pharma Ltd consolidated Q4 FY2026 profit at Rs. 4.59 crores
  • Bliss GVS Pharma Limited recommends final dividend of Rs. 1
  • Ajanta Pharma Ltd Q4 FY2026 consolidated net profit at Rs. 266.70 crores
  • Shelter Pharma Ltd receives orders worth USD 84,450
  • Anuh Pharma Ltd receives WHO PQ approval for Amodiaquine Hydrochloride USP
  • OneSource Supports Second Generic Semaglutide Approval in Canada
  • CuraTeQ Biologics Secures Health Canada NOC for Bevqolva™ Bevacizumab Biosimilar
  • Shelter Pharma Ltd receives international orders
  • Shelter Pharma Ltd secures order
  • OneSource's Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection
  • OneSource Specialty Pharma Ltd receives EU GMP Certificate for Sterile Product Division
  • Piramal Pharma Ltd consolidated Q4FY26 loss at Rs. 8.82 crores
  • Ajanta Pharma Ltd updates on USFDA inspection
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner
  • OneSource Specialty Pharma Ltd receives renewal of EU-GMP certification for Unit 2
  • Aurobindo Pharma receives USFDA Approval for Dextromethorphan Polistirex ExtendedRelease Oral Suspension, 30 mg/5 mL (OTC)
  • Aurobindo Pharma receives USFDA Approval for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL
  • Biocon Pharma Ltd receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • Aurobindo Pharma receives USFDA Approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
  • Aurobindo Pharma receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • CuraTeQ Biologics announces Positive Top-Line Results for Phase 3 Study of Omalizumab Biosimilar BP11

Latest Post

  • XTGlobal Infotech Limited Delivers Stellar Performance with ~39% Jump in PAT YoY
  • Mini Diamonds India Ltd announces Launch of Fancy Coloured LabGrown Diamond Jewellery Line through Namra Jewels Pvt Ltd
  • Gaudium IVF Delivers Record Q4FY26: Revenue, EBITDA and PAT
  • Unimech Aerospace and Manufacturing Ltd delivers strong Q4 FY26 Performance
  • EFC India Ltd reports strong results powering next phase of growth


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025